Applied Immune Technologies' Acquisition

Applied Immune Technologies was acquired by Adicet Bio on January 27, 2016.

Applied Immune Technologies (AIT) is a drug development company specializing in T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for a variety of therapeutic …

Articles about Applied Immune Technologies' Acquisition: